KINERET Side Effects

7026653-X | Arrhythmia
on Sep 14, 2010 Female patient from CANADA , child 5 years of age, was diagnosed with off label use and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?). Kineret dosage: .

7008657-6 | Hydrocephalus, Vertigo
Patient was taking Kineret (View Usage). Patient had the following side effects: hydrocephalus (What is hydrocephalus?), vertigo on Aug 21, 2010 from NORWAY Additional patient health information: Female patient , 68 years of age, . Kineret dosage: .

6992587-X | Cardiopulmonary Failure
Adverse event was reported on Aug 23, 2010 by a Female patient taking Kineret (View Usage) (Dosage: (100 Mg Subcutaneous)) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: ITALY , 64 years of age, After Kineret was administered, patient had the following side effects: cardiopulmonary failure.

6992516-9 | Asthenia, Influenza Like Illness, Myocarditis, Rash, Toxic Skin Eruption
on Aug 23, 2010 Female patient from FRANCE , child 4 years of age, weighting 28.66 lb, was diagnosed with juvenile arthritis and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, influenza like illness, myocarditis, rash (What is rash?), toxic skin eruption. Kineret dosage: (0.17 Ml Subcutaneous). During the same period patient was treated with SOLUPRED (View Solupred Review and Solupred Label ). Patient was hospitalized.


6973714-7 | Cardiopulmonary Failure
on Aug 23, 2010 Female patient from ITALY , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Kineret (View Usage). Patient had the following side effects: cardiopulmonary failure. Kineret dosage: (100 Mg Subcutaneous).

6960637-2 | Bronchitis, Emphysema, Non-small Cell Lung Cancer
Patient was taking Kineret (View Usage). After Kineret was administered, patient had the following side effects: bronchitis (What is bronchitis?), emphysema, non-small cell lung cancer on Aug 11, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Kineret dosage: . During the same period patient was treated with REMICADE (View Remicade Review and Remicade Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ARAVA (View Arava Review and Arava Label ), HUMIRA (View Humira Review and Humira Label ), ENBREL (View Enbrel Review and Enbrel Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MABTHERA (MABTHEA) (NOT SPECIFIED) (View Mabthera (mabthea) (not Specified) Review and Mabthera (mabthea) (not Specified) Label ). Patient was hospitalized.

6932014-1 | Acute Phase Reaction, Bordetella Infection, Injection Site Erythema, Injection Site Oedema, Rash, Sepsis, Upper Respiratory Tract Infection
Adverse event was reported on Aug 03, 2010 by a Female patient taking Kineret (View Usage) (Dosage: (100 Mg, Qd Subcutaneous)) was diagnosed with still's disease adult onset and. Location: CROATIA (local name: Hrvatska) , weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: acute phase reaction, bordetella infection, injection site erythema, injection site oedema, rash (What is rash?), sepsis (What is sepsis?), upper respiratory tract infection. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), GLUCOCORTICOIDS (View Glucocorticoids Review and Glucocorticoids Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6917507-5 | Histiocytosis Haematophagic
on Jul 23, 2010 Female patient from NETHERLANDS , 60 years of age, was diagnosed with still's disease adult onset and was treated with Kineret (View Usage). Patient had the following side effects: histiocytosis haematophagic. Kineret dosage: (100 Mg Qd Subcutaneous). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), HYDROCHLORTHIAZID (View Hydrochlorthiazid Review and Hydrochlorthiazid Label ), ATENOLOLUM (View Atenololum Review and Atenololum Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ACTONEL (View Actonel Review and Actonel Label ), OXALSOPAN (View Oxalsopan Review and Oxalsopan Label ), ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ). Patient was hospitalized.

6872422-0 | Anaemia, Apparent Life Threatening Event, Arthritis, Bone Marrow Failure, Convulsion, Dialysis, Hepatic Failure, Injection Site Necrosis
on Jul 06, 2010 Female patient from UNITED STATES , 16 years of age, weighting 132.0 lb, was diagnosed with juvenile arthritis and was treated with Kineret (View Usage). After Kineret was administered, patient had the following side effects: anaemia, apparent life threatening event, arthritis (What is arthritis?), bone marrow failure, convulsion, dialysis (What is dialysis?), hepatic failure, injection site necrosis. Kineret dosage: (100 Mg Qd For 6 Weeks Subcutaneous). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6781729-7 | Acute Myeloid Leukaemia, Pneumonia
Patient was taking Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, pneumonia (What is pneumonia?) on Jun 03, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 103.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Kineret dosage: 100 Mg.

6781719-4 | Skin Cancer
Adverse event was reported on Jun 03, 2010 by a Female patient taking Kineret (View Usage) (Dosage: 100 Mg) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , weighting 103.6 lb, Patient had the following side effects: skin cancer (What is skin cancer?).

6754808-8 | Device Dislocation, Obstructive Airways Disorder, Respiratory Distress
on May 14, 2010 Female patient from ITALY , 14 years of age, was treated with Kineret (View Usage). After Kineret was administered, patient had the following side effects: device dislocation, obstructive airways disorder, respiratory distress. Kineret dosage: (100 Mg Subcutaneous).

6731892-9 | Anaemia, Bone Marrow Failure, Condition Aggravated, Convulsion, Dialysis, Hepatic Failure, Histiocytosis Haematophagic, Injection Site Necrosis
on Apr 27, 2010 Female patient from UNITED STATES , 16 years of age, weighting 132.0 lb, was diagnosed with juvenile arthritis and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, bone marrow failure, condition aggravated, convulsion, dialysis (What is dialysis?), hepatic failure, histiocytosis haematophagic, injection site necrosis. Kineret dosage: 100 Mg Qd For 6 Weeks Subcutaneous. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6668655-9 | Skin Cancer
Patient was taking Kineret (View Usage). Patient had the following side effects: skin cancer (What is skin cancer?) on Mar 18, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 158.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Kineret dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CALCIUM (View Calcium Review and Calcium Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6619208-X | Anaemia, Bone Marrow Failure, Condition Aggravated, Convulsion, Dialysis, Hepatic Failure, Histiocytosis Haematophagic, Injection Site Necrosis
Adverse event was reported on Feb 12, 2010 by a Female patient taking Kineret (View Usage) (Dosage: 100 Mg Qd For 6 Weeks Subcutaneous) was diagnosed with juvenile arthritis and. Location: UNITED STATES , 16 years of age, weighting 132.0 lb, After Kineret was administered, patient had the following side effects: anaemia, bone marrow failure, condition aggravated, convulsion, dialysis (What is dialysis?), hepatic failure, histiocytosis haematophagic, injection site necrosis. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6614656-6 | Asthenia, Condition Aggravated, Influenza Like Illness, Myocarditis, Pyrexia, Toxic Skin Eruption
on Feb 09, 2010 Female patient from FRANCE , child 4 years of age, weighting 28.66 lb, was diagnosed with juvenile arthritis and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, condition aggravated, influenza like illness, myocarditis, pyrexia, toxic skin eruption. Kineret dosage: (0.17 Ml Subcutaneous). Patient was hospitalized.

6598038-1 | Infection, Pulmonary Embolism, Pulmonary Fibrosis
on Jan 26, 2010 Female patient from GERMANY , 74 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Kineret (View Usage). Patient had the following side effects: infection (What is infection?), pulmonary embolism (What is pulmonary embolism?), pulmonary fibrosis (What is pulmonary fibrosis?). Kineret dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), TOCILIZUMAB (View Tocilizumab Review and Tocilizumab Label ), DECORTIN (View Decortin Review and Decortin Label ), CALCIMAGON (CALCIMAGON) (View Calcimagon (calcimagon) Review and Calcimagon (calcimagon) Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CELEBREX (View Celebrex Review and Celebrex Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

6581368-7 | Depression
Patient was taking Kineret (View Usage). After Kineret was administered, patient had the following side effects: depression (What is depression?) on Jan 18, 2010 from FRANCE Additional patient health information: Male patient , 42 years of age, was diagnosed with still's disease adult onset and. Kineret dosage: 100 Mg Qd Subcutaneous. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), FENSAID (View Fensaid Review and Fensaid Label ). Patient was hospitalized.

6568410-4 | Lung Hyperinflation, Lung Neoplasm, Obliterative Bronchiolitis
Adverse event was reported on Jan 11, 2010 by a Female patient taking Kineret (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , weighting 178.6 lb, Patient experienced the following unwanted or unexpected effects: lung hyperinflation, lung neoplasm, obliterative bronchiolitis. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BECOTIDE (View Becotide Review and Becotide Label ), IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ), SEREVENT (View Serevent Review and Serevent Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

6551437-6 | Carcinoid Tumour
on Jan 04, 2010 Male patient from UNITED KINGDOM , weighting 269.0 lb, was diagnosed with still's disease adult onset and was treated with Kineret (View Usage). Patient had the following side effects: carcinoid tumour. Kineret dosage: Subcutaneous. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ). Patient was hospitalized.

6551132-3 | Arthralgia, Asthenia, Back Pain, Chills, Constipation, Cytolytic Hepatitis, Haemorrhoids, Hepatosplenomegaly, Hypoalbuminaemia
on Jan 05, 2010 Female patient from FRANCE , weighting 140.0 lb, was diagnosed with still's disease adult onset and was treated with Kineret (View Usage). After Kineret was administered, patient had the following side effects: arthralgia, asthenia, back pain (What is back pain?), chills, constipation (What is constipation?), cytolytic hepatitis, haemorrhoids, hepatosplenomegaly, hypoalbuminaemia. Kineret dosage: (100 Mg Subcutaneous). During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), NEXIUM (View Nexium Review and Nexium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ANTIBIOTICS () (View Antibiotics () Review and Antibiotics () Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TAZOCILLINE (View Tazocilline Review and Tazocilline Label ). Patient was hospitalized.

6532505-1 | Lymphadenopathy
Patient was taking Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: lymphadenopathy on Dec 14, 2009 from ITALY Additional patient health information: Male patient , 47 years of age, was diagnosed with still's disease adult onset and. Kineret dosage: (100 Mg Qd Subcutaneous). During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), INDOXEN (View Indoxen Review and Indoxen Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ).

6521169-9 | Bone Marrow Failure, Convulsion, Injection Site Necrosis, Injection Site Reaction, Multi-organ Failure, Pyrexia, Rash, Respiratory Failure, Type Iii Immune Complex Mediated Reaction
Adverse event was reported on Dec 04, 2009 by a Female patient taking Kineret (View Usage) (Dosage: (100 Mg Stopped Upon Hospitalisation Subcutaneous)) was diagnosed with juvenile arthritis and. Location: UNITED STATES , 17 years of age, Patient had the following side effects: bone marrow failure, convulsion, injection site necrosis, injection site reaction, multi-organ failure, pyrexia, rash (What is rash?), respiratory failure, type iii immune complex mediated reaction. Patient was hospitalized.

6506023-0 | Injection Site Reaction, Myositis
on Dec 17, 2009 Male patient from UNITED STATES , weighting 230.0 lb, was diagnosed with juvenile arthritis and was treated with Kineret (View Usage). After Kineret was administered, patient had the following side effects: injection site reaction, myositis (What is myositis?). Kineret dosage: .

6496669-0 | Gastrointestinal Carcinoma, Inflammation, Lung Neoplasm, Obliterative Bronchiolitis
on Nov 24, 2009 Female patient from UNITED KINGDOM , weighting 178.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal carcinoma, inflammation, lung neoplasm, obliterative bronchiolitis. Kineret dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BECOTIDE (View Becotide Review and Becotide Label ), IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ), SEREVENT (View Serevent Review and Serevent Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

6496667-7 | Metastasis, Renal Cancer Recurrent
Patient was taking Kineret (View Usage). Patient had the following side effects: metastasis, renal cancer recurrent on Nov 26, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 191.8 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Kineret dosage: (). During the same period patient was treated with SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ). Patient was hospitalized.

6489697-2 | Diarrhoea
Adverse event was reported on Nov 19, 2009 by a Female patient taking Kineret (View Usage) (Dosage: 100 Mg Subcutaneous) was diagnosed with castleman's disease and. Location: UNITED STATES , 62 years of age, After Kineret was administered, patient had the following side effects: diarrhoea. Patient was hospitalized.

6479859-2 | Skin Cancer
on Nov 16, 2009 Female patient from UNITED KINGDOM , weighting 158.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: skin cancer (What is skin cancer?). Kineret dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CALCIUM (View Calcium Review and Calcium Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6468556-5 | Escherichia Infection, Injection Site Pain, Skin Infection
on Nov 13, 2009 Female patient from UNITED STATES , 53 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?), rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Kineret (View Usage). Patient had the following side effects: escherichia infection, injection site pain, skin infection. Kineret dosage: 100 Mg Subcutaneous. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ). Patient was hospitalized.

6443858-7 | Amyotrophic Lateral Sclerosis, Blood Alkaline Phosphatase, Disease Complication, Disease Progression, Injection Site Reaction, Skin Lesion, Yawning
Patient was taking Kineret (View Usage). After Kineret was administered, patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), blood alkaline phosphatase, disease complication, disease progression, injection site reaction, skin lesion, yawning on Oct 30, 2009 from NETHERLANDS Additional patient health information: Female patient , 62 years of age, was diagnosed with urticaria thermal, amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Kineret dosage: (100 Mg Subcutaneous).

6416402-8 | Chronic Infantile Neurological Cutaneous And Articular Syndrome, Condition Aggravated, Disease Recurrence
Adverse event was reported on Oct 05, 2009 by a Female patient taking Kineret (View Usage) (Dosage: 224 Mg;) was diagnosed with chronic infantile neurological cutaneous and articular syndrome and. Location: NETHERLANDS , 20 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: chronic infantile neurological cutaneous and articular syndrome, condition aggravated, disease recurrence.

6411209-X | Abdominal Distension, Abdominal Pain Lower, Colon Cancer, Frequent Bowel Movements, Lymphadenopathy
on Oct 01, 2009 Female patient from UNITED KINGDOM , weighting 101.4 lb, was treated with Kineret (View Usage). Patient had the following side effects: abdominal distension, abdominal pain lower, colon cancer, frequent bowel movements, lymphadenopathy. Kineret dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6399065-X | Hypotension, Injection Site Erythema, Viral Infection, Vomiting
on Sep 21, 2009 Female patient from UNITED STATES , child 6 years of age, was diagnosed with juvenile arthritis and was treated with Kineret (View Usage). After Kineret was administered, patient had the following side effects: hypotension, injection site erythema, viral infection (What is viral infection?), vomiting. Kineret dosage: See Image. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ). Patient was hospitalized.

6392238-1 | Disease Progression, Juvenile Arthritis, Pyrexia, Viral Infection, Vomiting
Patient was taking Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, juvenile arthritis, pyrexia, viral infection (What is viral infection?), vomiting on Sep 16, 2009 from FRANCE Additional patient health information: Female patient , weighting 28.66 lb, was diagnosed with juvenile arthritis and. Kineret dosage: (26 Mg Subcutaneous). Patient was hospitalized.

6392237-X | Upper Respiratory Tract Infection
Adverse event was reported on Sep 16, 2009 by a Female patient taking Kineret (View Usage) (Dosage: ) was diagnosed with still's disease adult onset and. Location: CROATIA (local name: Hrvatska) , 32 years of age, Patient had the following side effects: upper respiratory tract infection. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), GLUCOCORTICOIDS (View Glucocorticoids Review and Glucocorticoids Label ). Patient was hospitalized.

6314764-3 | Dyspnoea, Fungal Infection, Lung Neoplasm, Pyrexia, Toxic Skin Eruption
on Jul 07, 2009 Female patient from FRANCE , weighting 138.9 lb, was diagnosed with still's disease adult onset and was treated with Kineret (View Usage). After Kineret was administered, patient had the following side effects: dyspnoea, fungal infection (What is fungal infection?), lung neoplasm, pyrexia, toxic skin eruption. Kineret dosage: 100 Mg Subcutaneous, (100 Mg Subcutaneous). During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), INEXIUM (View Inexium Review and Inexium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized and became disabled.

6312881-5 | Abdominal Distension, Alanine Aminotransferase Increased, Arthritis, Aspartate Aminotransferase Increased, Atelectasis, Blood Pressure Decreased, Condition Aggravated, Dermatitis, Haemoglobin Decreased
on Jul 28, 2009 Female patient from UNITED STATES , weighting 71.43 lb, was diagnosed with juvenile arthritis and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, alanine aminotransferase increased, arthritis (What is arthritis?), aspartate aminotransferase increased, atelectasis, blood pressure decreased, condition aggravated, dermatitis, haemoglobin decreased. Kineret dosage: 50 Mg Subcutaneous. During the same period patient was treated with THALOMID (50 Mg Oral) (View Thalomid Review and Thalomid Label ), METHOTREXATE (WYETH LEDERLE) (0.6 Ml 1 X Week Subcutaneous) (View Methotrexate (wyeth Lederle) Review and Methotrexate (wyeth Lederle) Label ), ACRIVASTINE (View Acrivastine Review and Acrivastine Label ), GENOTROPIN (View Genotropin Review and Genotropin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), HORMONES NOS (View Hormones Nos Review and Hormones Nos Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

6278217-3 | Osteonecrosis
Patient was taking Kineret (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Jul 03, 2009 from FRANCE Additional patient health information: Male patient , 35 years of age, was diagnosed with still's disease adult onset and. Kineret dosage: (100 Mg/kg Qd). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6220295-1 | Haematocrit Decreased, Haemoglobin Decreased, Platelet Count Increased
Adverse event was reported on Apr 28, 2009 by a Male patient taking Kineret (View Usage) (Dosage: (100 Mg Qd Subcutaneous), (100 Mg Qd Subcutaneous)) . Location: GERMANY , weighting 160.9 lb, After Kineret was administered, patient had the following side effects: haematocrit decreased, haemoglobin decreased, platelet count increased. During the same period patient was treated with ANTIINFLAMMATORY/ANTIRHEUMATIC NON STEROIDS (View Antiinflammatory/antirheumatic Non-steroids Review and Antiinflammatory/antirheumatic Non-steroids Label ), GLUCOCORTICOIDS (View Glucocorticoids Review and Glucocorticoids Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ETANERCEPT (View Etanercept Review and Etanercept Label ), CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ). Patient was hospitalized.

6220292-6 | Autoimmune Disorder, Condition Aggravated, Herpes Virus Infection, Neutropenia, Off Label Use, White Blood Cell Count Decreased
on Apr 17, 2009 Female patient from FRANCE , weighting 83.78 lb, was diagnosed with blood immunoglobulin d increased and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune disorder, condition aggravated, herpes virus infection, neutropenia, off label use, white blood cell count decreased. Kineret dosage: (100 Mg Subcutaneous), (50 Mg Subcutaneous). During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

6139045-2 | Cataract, Hypermetropia, Inflammation, Injection Site Erythema, Injection Site Pain, Lipoatrophy, Skin Chapped, Visual Acuity Reduced Transiently, Visual Field Defect
on Mar 26, 2009 Female patient from FRANCE , weighting 130.1 lb, was diagnosed with juvenile arthritis and was treated with Kineret (View Usage). Patient had the following side effects: cataract (What is cataract?), hypermetropia, inflammation, injection site erythema, injection site pain, lipoatrophy, skin chapped, visual acuity reduced transiently, visual field defect. Kineret dosage: . During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ).

6139042-7 | Thyroid Cancer
Patient was taking Kineret (View Usage). After Kineret was administered, patient had the following side effects: thyroid cancer (What is thyroid cancer?) on Mar 27, 2009 from UNITED KINGDOM Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Kineret dosage: . During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), ACETAMINOPHEN WITH PROPOXYPHENE HCL TAB (View Acetaminophen With Propoxyphene Hcl Tab Review and Acetaminophen With Propoxyphene Hcl Tab Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), EVISTA (View Evista Review and Evista Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

6139040-3 | Cellulitis Gangrenous, Injection Site Cellulitis
Adverse event was reported on Mar 23, 2009 by a Male patient taking Kineret (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: cellulitis gangrenous, injection site cellulitis. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), DIFFU K (View Diffu K Review and Diffu K Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ). Patient was hospitalized.

6130104-7 | Granuloma Skin
on Mar 13, 2009 Female patient from UNITED STATES , 52 years of age, weighting 145.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Kineret (View Usage). Patient had the following side effects: granuloma skin. Kineret dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), MEDROL (View Medrol Review and Medrol Label ), NEXIUM (View Nexium Review and Nexium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6123039-7 | Exfoliative Rash, Lymphocytic Infiltration, Rash Erythematous, Rash Pruritic, Rheumatoid Arthritis, Urticaria
on Mar 06, 2009 Male patient from GERMANY , 57 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Kineret (View Usage). After Kineret was administered, patient had the following side effects: exfoliative rash, lymphocytic infiltration, rash erythematous, rash pruritic, rheumatoid arthritis (What is rheumatoid arthritis?), urticaria. Kineret dosage: . During the same period patient was treated with ANTIINFLAMMATORY NOS (View Antiinflammatory Nos Review and Antiinflammatory Nos Label ), GLUCOCORTICOIDS (View Glucocorticoids Review and Glucocorticoids Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

6110456-4 | Herpes Virus Infection, Neutropenia
Patient was taking Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: herpes virus infection, neutropenia on Mar 02, 2009 from FRANCE Additional patient health information: Female patient , weighting 83.78 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Kineret dosage: . During the same period patient was treated with ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

6104972-9 | Skin Cancer
Adverse event was reported on Feb 27, 2009 by a Male patient taking Kineret (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , weighting 134.5 lb, Patient had the following side effects: skin cancer (What is skin cancer?). During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6104932-8 | Myocarditis
on Feb 25, 2009 Female patient from UNITED KINGDOM , child 5 years of age, weighting 29.10 lb, was diagnosed with arthritis (What is arthritis?) and was treated with Kineret (View Usage). After Kineret was administered, patient had the following side effects: myocarditis. Kineret dosage: . During the same period patient was treated with SEPTRIN (View Septrin Review and Septrin Label ). Patient was hospitalized.

6086029-9 | Eosinophilic Cellulitis
on Feb 09, 2009 Female patient from FRANCE , 48 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Kineret (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilic cellulitis. Kineret dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ). Patient was hospitalized.

6086026-3 | Cellulitis Gangrenous, Injection Site Cellulitis, Lymphangitis
Patient was taking Kineret (View Usage). Patient had the following side effects: cellulitis gangrenous, injection site cellulitis, lymphangitis on Feb 09, 2009 from FRANCE Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Kineret dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), DIFFU K (View Diffu K Review and Diffu K Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ). Patient was hospitalized.